世界の胆道閉鎖症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biliary Atresia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3899 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、胆道閉鎖症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・胆道閉鎖症治療の市場動向 ・企業の競争状況、市場シェア ・胆道閉鎖症治療の種類別市場規模と予測2016-2027（薬物治療、手術治療） ・胆道閉鎖症治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・胆道閉鎖症治療の北米市場規模2016-2027（アメリカ、カナダ） ・胆道閉鎖症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆道閉鎖症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆道閉鎖症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆道閉鎖症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Daiichi Sankyo、Eisai、Johnson & Johnson、Novartis、Pfizer） ・結論

Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder.

Market Analysis and Insights: Global Biliary Atresia Treatment Market
The global Biliary Atresia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biliary Atresia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biliary Atresia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biliary Atresia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biliary Atresia Treatment market.

Global Biliary Atresia Treatment Scope and Market Size
Biliary Atresia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biliary Atresia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Treatment
Surgery Treatment

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Daiichi Sankyo
Eisai
Johnson & Johnson
Novartis
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Atresia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Surgery Treatment
1.3 Market by Application
1.3.1 Global Biliary Atresia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biliary Atresia Treatment Market Perspective (2016-2027)
2.2 Biliary Atresia Treatment Growth Trends by Regions
2.2.1 Biliary Atresia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biliary Atresia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Biliary Atresia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Biliary Atresia Treatment Industry Dynamic
2.3.1 Biliary Atresia Treatment Market Trends
2.3.2 Biliary Atresia Treatment Market Drivers
2.3.3 Biliary Atresia Treatment Market Challenges
2.3.4 Biliary Atresia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biliary Atresia Treatment Players by Revenue
3.1.1 Global Top Biliary Atresia Treatment Players by Revenue (2016-2021)
3.1.2 Global Biliary Atresia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Biliary Atresia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biliary Atresia Treatment Revenue
3.4 Global Biliary Atresia Treatment Market Concentration Ratio
3.4.1 Global Biliary Atresia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Atresia Treatment Revenue in 2020
3.5 Biliary Atresia Treatment Key Players Head office and Area Served
3.6 Key Players Biliary Atresia Treatment Product Solution and Service
3.7 Date of Enter into Biliary Atresia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biliary Atresia Treatment Breakdown Data by Type
4.1 Global Biliary Atresia Treatment Historic Market Size by Type (2016-2021)
4.2 Global Biliary Atresia Treatment Forecasted Market Size by Type (2022-2027)

5 Biliary Atresia Treatment Breakdown Data by Application
5.1 Global Biliary Atresia Treatment Historic Market Size by Application (2016-2021)
5.2 Global Biliary Atresia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biliary Atresia Treatment Market Size (2016-2027)
6.2 North America Biliary Atresia Treatment Market Size by Type
6.2.1 North America Biliary Atresia Treatment Market Size by Type (2016-2021)
6.2.2 North America Biliary Atresia Treatment Market Size by Type (2022-2027)
6.2.3 North America Biliary Atresia Treatment Market Size by Type (2016-2027)
6.3 North America Biliary Atresia Treatment Market Size by Application
6.3.1 North America Biliary Atresia Treatment Market Size by Application (2016-2021)
6.3.2 North America Biliary Atresia Treatment Market Size by Application (2022-2027)
6.3.3 North America Biliary Atresia Treatment Market Size by Application (2016-2027)
6.4 North America Biliary Atresia Treatment Market Size by Country
6.4.1 North America Biliary Atresia Treatment Market Size by Country (2016-2021)
6.4.2 North America Biliary Atresia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Biliary Atresia Treatment Market Size (2016-2027)
7.2 Europe Biliary Atresia Treatment Market Size by Type
7.2.1 Europe Biliary Atresia Treatment Market Size by Type (2016-2021)
7.2.2 Europe Biliary Atresia Treatment Market Size by Type (2022-2027)
7.2.3 Europe Biliary Atresia Treatment Market Size by Type (2016-2027)
7.3 Europe Biliary Atresia Treatment Market Size by Application
7.3.1 Europe Biliary Atresia Treatment Market Size by Application (2016-2021)
7.3.2 Europe Biliary Atresia Treatment Market Size by Application (2022-2027)
7.3.3 Europe Biliary Atresia Treatment Market Size by Application (2016-2027)
7.4 Europe Biliary Atresia Treatment Market Size by Country
7.4.1 Europe Biliary Atresia Treatment Market Size by Country (2016-2021)
7.4.2 Europe Biliary Atresia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biliary Atresia Treatment Market Size (2016-2027)
8.2 Asia-Pacific Biliary Atresia Treatment Market Size by Type
8.2.1 Asia-Pacific Biliary Atresia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biliary Atresia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biliary Atresia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Biliary Atresia Treatment Market Size by Application
8.3.1 Asia-Pacific Biliary Atresia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biliary Atresia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biliary Atresia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Biliary Atresia Treatment Market Size by Region
8.4.1 Asia-Pacific Biliary Atresia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biliary Atresia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biliary Atresia Treatment Market Size (2016-2027)
9.2 Latin America Biliary Atresia Treatment Market Size by Type
9.2.1 Latin America Biliary Atresia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Biliary Atresia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Biliary Atresia Treatment Market Size by Type (2016-2027)
9.3 Latin America Biliary Atresia Treatment Market Size by Application
9.3.1 Latin America Biliary Atresia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Biliary Atresia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Biliary Atresia Treatment Market Size by Application (2016-2027)
9.4 Latin America Biliary Atresia Treatment Market Size by Country
9.4.1 Latin America Biliary Atresia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Biliary Atresia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biliary Atresia Treatment Market Size (2016-2027)
10.2 Middle East & Africa Biliary Atresia Treatment Market Size by Type
10.2.1 Middle East & Africa Biliary Atresia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biliary Atresia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biliary Atresia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Biliary Atresia Treatment Market Size by Application
10.3.1 Middle East & Africa Biliary Atresia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biliary Atresia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biliary Atresia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Biliary Atresia Treatment Market Size by Country
10.4.1 Middle East & Africa Biliary Atresia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biliary Atresia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Biliary Atresia Treatment Introduction
11.1.4 AstraZeneca Revenue in Biliary Atresia Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Details
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Biliary Atresia Treatment Introduction
11.2.4 Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2016-2021)
11.2.5 Daiichi Sankyo Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Biliary Atresia Treatment Introduction
11.3.4 Eisai Revenue in Biliary Atresia Treatment Business (2016-2021)
11.3.5 Eisai Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Biliary Atresia Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Biliary Atresia Treatment Introduction
11.5.4 Novartis Revenue in Biliary Atresia Treatment Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Biliary Atresia Treatment Introduction
11.6.4 Pfizer Revenue in Biliary Atresia Treatment Business (2016-2021)
11.6.5 Pfizer Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biliary Atresia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgery Treatment
Table 4. Global Biliary Atresia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biliary Atresia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biliary Atresia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biliary Atresia Treatment Market Share by Regions (2016-2021)
Table 8. Global Biliary Atresia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biliary Atresia Treatment Market Share by Regions (2022-2027)
Table 10. Biliary Atresia Treatment Market Trends
Table 11. Biliary Atresia Treatment Market Drivers
Table 12. Biliary Atresia Treatment Market Challenges
Table 13. Biliary Atresia Treatment Market Restraints
Table 14. Global Biliary Atresia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biliary Atresia Treatment Market Share by Players (2016-2021)
Table 16. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2020)
Table 17. Ranking of Global Top Biliary Atresia Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biliary Atresia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biliary Atresia Treatment Product Solution and Service
Table 21. Date of Enter into Biliary Atresia Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biliary Atresia Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Biliary Atresia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biliary Atresia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biliary Atresia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biliary Atresia Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Biliary Atresia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biliary Atresia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biliary Atresia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biliary Atresia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biliary Atresia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biliary Atresia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biliary Atresia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biliary Atresia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biliary Atresia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biliary Atresia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biliary Atresia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biliary Atresia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biliary Atresia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biliary Atresia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biliary Atresia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biliary Atresia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biliary Atresia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biliary Atresia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biliary Atresia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biliary Atresia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biliary Atresia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biliary Atresia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biliary Atresia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biliary Atresia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biliary Atresia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biliary Atresia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biliary Atresia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biliary Atresia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Biliary Atresia Treatment Product
Table 64. AstraZeneca Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Daiichi Sankyo Company Details
Table 67. Daiichi Sankyo Business Overview
Table 68. Daiichi Sankyo Biliary Atresia Treatment Product
Table 69. Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 70. Daiichi Sankyo Recent Development
Table 71. Eisai Company Details
Table 72. Eisai Business Overview
Table 73. Eisai Biliary Atresia Treatment Product
Table 74. Eisai Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 75. Eisai Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Biliary Atresia Treatment Product
Table 79. Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Biliary Atresia Treatment Product
Table 84. Novartis Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 85. Novartis Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Biliary Atresia Treatment Product
Table 89. Pfizer Revenue in Biliary Atresia Treatment Business (2016-2021) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Atresia Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Surgery Treatment Features
Figure 4. Global Biliary Atresia Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Biliary Atresia Treatment Report Years Considered
Figure 9. Global Biliary Atresia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Biliary Atresia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Biliary Atresia Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Biliary Atresia Treatment Market Share by Regions (2022-2027)
Figure 13. Global Biliary Atresia Treatment Market Share by Players in 2020
Figure 14. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Biliary Atresia Treatment Revenue in 2020
Figure 16. Global Biliary Atresia Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Biliary Atresia Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Biliary Atresia Treatment Market Share by Type (2016-2027)
Figure 20. North America Biliary Atresia Treatment Market Share by Application (2016-2027)
Figure 21. North America Biliary Atresia Treatment Market Share by Country (2016-2027)
Figure 22. United States Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biliary Atresia Treatment Market Share by Type (2016-2027)
Figure 26. Europe Biliary Atresia Treatment Market Share by Application (2016-2027)
Figure 27. Europe Biliary Atresia Treatment Market Share by Country (2016-2027)
Figure 28. Germany Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biliary Atresia Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Biliary Atresia Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Biliary Atresia Treatment Market Share by Region (2016-2027)
Figure 38. China Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biliary Atresia Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Biliary Atresia Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Biliary Atresia Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biliary Atresia Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Biliary Atresia Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Biliary Atresia Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Biliary Atresia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 58. Daiichi Sankyo Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 59. Eisai Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Biliary Atresia Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---